Citation: | LIU Hui-rong, ZHANG Feng-mei, ZHAO Ai-xia, LI Hao-yang, LIU Li, ZHANG Meng, SUN Hui-yue. Clinical Study on Treating Diabetic Retinopathy by Rosiglitazone Combined with Anxue Granules[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(6): 659-663. |
[1] |
CARUMATHI SG, RISWANA BD, LI CB, et al. Incidence and progression of diabetic retinopathy: A systematic review[J]. Diab Endocrinol, 2018, 7(2): 140-149.
|
[2] |
CHIARA BM, GIAN ML, FILIPPO D, et al. Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy[J]. Biochem Pharm, 2018, 158(12): 13-26.
|
[3] |
LUIS BF, NIPON TU, SANSANEE A. Diagnosis of diabetic retinopathy based on holistic texture and local retinal features[J]. Inform Sci, 2018, 475(2): 44-66.
|
[4] |
SHAKOOR BA, ADAM ELIAS B, HENRIK ULLITS A, et al. Assessment of diurnal melatonin, cortisol, activity, and sleep-wake cycle in patients with and without diabetic retinopathy[J]. Sleep Med, 2018, 54(2): 35-42.
|
[5] |
中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014 年) [J]. 中华眼科杂志, 2014, 50(11): 851-865.
|
[6] |
中华中医药学会. 糖尿病视网膜病变中医诊疗指南[J]. 中国中医药现代远程教育, 2011, 9(4): 154-155.
|
[7] |
第三届全国眼科学术会议.糖尿病性视网膜病变分期标准[J].中华眼科杂志,1985,21:113.
|
[8] |
BALARATNASIN C, INOUE M, AHN S, et al. Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion[J]. Ophthalmology, 2016, 123(11): 2352-2367.
|
[9] |
FREIBERG FJ, PFAU M, WONS J, et al. Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(6): 1051-1058.
|
[10] |
GHASEMI FK, IAFE NA, HUBSCHMAN JP, et al. Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion[J]. Invest Ophthalmol Vis Sci, 2017, 58(1): 30-34.
|
[11] |
SUGIOKA K, SAITO A, KUSAKA S, et al. Identification of vitreous proteins in retinopathy of prematurity[J]. Biochem Biophys Res Commun, 2017, 488(3): 483-488.
|
[12] |
CHANDRA S, SHETH J, ANANTHARAMAN G,et al. Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration[J]. Am J Ophthalmol Case Rep, 2018, 4(9): 41-44.
|
[13] |
位庚,邢玉微,曹柳,等.津力达颗粒联合通心络胶囊治疗糖尿病视网膜病变的临床观察[J].中国实验方剂学杂志, 2018, 24(18): 170-174.
|
[14] |
〖JP2〗SAWADA O, ICHIYAMA Y,OBATA S, et al. Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256(7): 1275-1280.〖JP〗
|
[15] |
ANDREANOS K, ROTSOS T, KYMIONIS G, et al. Optical coherence tomography angiography of foveal neovascularization in diabetic retinopathy[J]. Case Rep Ophthalmol, 2018, 9(1): 87-91.
|
[16] |
JEON SJ, PARK HL, LEE JH, et al. Relationship between systemic vascular characteristics and retinal nerve fiber layer loss in patients with type 2 diabetes[J]. Sci Rep, 2018, 8(1): 10510.
|
[17] |
〖JP2〗SHI R, GUO Z, WANG F, et al. Alterations in retinal nerve fiber layer thickness in early stages of diabetic retinopathy and potential risk factors[J]. Curr Eye Res, 2018, 43(2): 244-253.〖JP〗
|
[18] |
YE H, YU M, LU L, et al. Electroretinogram evaluation for the treatment of proliferative diabetic retinopathy by short-pulse pattern scanning laser panretinal photocoagulation[J]. Lasers Med Sci, 2018, 33(5): 1095-1102.
|